Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 350 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Deepak B.

United States

USD 350 /hr

CMO | Clinical Development | Medical Affairs | CEO@Adaptive Research: Democratizing Clinical Trials

Profile Summary

I am a transformative leader in the Lifesciences industry, leveraging a background as a physician-scientist to drive strategic advancements in the clinical development and medical affairs sectors. My expertise spans across the clinical, academic, and pharma/biotech spheres, where I consult with various industry players in the pharmaceutical domain. The major areas that I enjoy are: ► Clinical development strategy: Necessary evidence generation for regulatory approval, market adoption and reimbursement, while reducing time and cost of clinical development. ► Market positioning & product launch: Medical affairs strategy and support for product launches and lifecycle management, ensuring products are optimally positioned for success. ► Technology evaluation: Assessing new technologies for product-market fit, development status, and investment potential. In addition, as the Co-founder & CEO of Adaptive Research, I've been blessed to lead a dynamic startup team committed to reshaping how clinical trials are managed. My role encompasses crafting the company's vision & strategic trajectory, cultivating valuable relationships with healthcare stakeholders and sponsors, and ensuring our community-oriented clinical trials operate flawlessly. I am continually exploring innovative methods to enhance our processes, broaden our collaboration network, and improve our service offerings. All our efforts converge towards one central objective: to uplift patient care and propel the forward momentum of medical research. I thrive in balancing the structured world of medical and regulatory environments with the innovative and dynamic realm of commercial value creation. My ultimate aim is to push the boundaries of healthcare for better patient outcomes, while concurrently generating value for all stakeholders involved. As a leader, I bring together crucial considerations spanning science, medicine, regulatory aspects, customer service, marketing, product differentiation, and commercial strategies to foster innovation and success. I am open to roles as a CEO, CMO, Executive Director, VP, etc. where I can leverage my skills in building new organizations, departments, and capabilities.

Subject Matter Expertise

• ☆ Drug Development
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Clinical Trials
• ☆ Medical Affairs
• ☆ Product Launch Support

Services

• Writing
• Research
• Consulting
• Product Development

Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing

Research Market Research, User Research, Meta-Research, Gap Analysis, Scientific and Technical Research, Systematic Literature Review

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Scientific and Technical Consulting, Regulatory Consulting

Product Development Product Launch Support

Work Experience

President & CEO

Adaptive Research Inc

August 2020 - Present

Clinical Development / Medical Affairs

The Bracken Group | Medical Imaging Consultancy

March 2019 - Present

Senior Director, Medical Affairs & Clinical Development

ImaginAb

January 2018 - March 2019

Medical Director, US Medical Affairs

Piramal Imaging

February 2016 - January 2018

Clinical Trial Research Process Manager

Stanford University School of Medicine

September 2015 - February 2016

Researcher, Research Associate

Stanford University School of Medicine

June 2007 - September 2015

Physician

PGIMER & Unique Medical Center

August 2005 - May 2007

Education

Medical Degree (MD)

National board of examinations

June 2002 - June 2005

MBBS

Berhampur university

August 1995 - October 2001

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Jelena Levi, Heying Duan, Shahriar Yaghoubi, Juliet Packiasamy, Lyna Huynh, Tina Lam, Faiq Shaikh, Deepak Behera, Hong Song, Joseph Blecha, et al.(2022). Biodistribution of a Mitochondrial Metabolic Tracer, [18F]F-AraG, in Healthy Volunteers . Molecular Imaging. 2022. p. 1--9. Hindawi Limited

Henry VanBrocklin, Denis Beckford Vera, Brailee Schulte, Robert Flavell, Youngho Seo, Jelena Levi, Faiq Shaikh, Deepak Behera, Timothy Henrich (2020). Imaging viral load and T cell activation in HIV: Tools for cure development . Journal of Nuclear Medicine.

Neeta Pandit-Taskar, Michael A. Postow, Matthew D. Hellmann, James J. Harding, Christopher A. Barker, Joseph A. O’Donoghue, Martha Ziolkowska, Shutian Ruan, Serge K. Lyashchenko, Frank Tsai, et al.(2020). First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting . Journal of Nuclear Medicine. 61. (4). p. 512--519. Society of Nuclear Medicine

Aileen Hoehne, Michelle L. James, Israt S. Alam, John A. Ronald, Bernadette Schneider, Aloma D’Souza, Timothy H. Witney, Lauren E. Andrews, Haley C. Cropper, Deepak Behera, et al.(2018). [18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis . Journal of Neuroinflammation. 15. (1). Springer Science and Business Media {LLC}

Bin Shen, Jun Hyung Park, Trine Hjørnevik, Peter W. Cipriano, Daehyun Yoon, Praveen K. Gulaka, Dawn Holly, Deepak Behera, Bonnie A. Avery, Sanjiv S. Gambhir, et al.(2017). Radiosynthesis and First-In-Human PET/MRI Evaluation with Clinical-Grade [18F]FTC-146 . Molecular Imaging and Biology. 19. (5). p. 779--786. Springer Science and Business Media {LLC}

Bin Shen, Deepak Behera, Michelle L. James, Samantha T. Reyes, Lauren Andrews, Peter W. Cipriano, Michael Klukinov, Amanda Brosius Lutz, Timur Mavlyutov, Jarrett Rosenberg, et al.(2017). Visualizing Nerve Injury in a Neuropathic Pain Model with [¹⁸F]FTC-146 PET/MRI . Theranostics. 7. (11). p. 2794--2805. Ivyspring International Publisher

Yingding Xu, DaeHyun Yoon, Deepak Behera, Dawn Holley, Ian Carroll, Matthew Smuck, Brian Hargreaves, Erik Mittra, Sandip Biswal (2016). [18F]FDG PET/MRI of patients with chronic pain alters management: Early experience .

Sandip Biswal, Deepak Behera, Dae Hyun Yoon, Dawn Holley, Ma Agnes Martinez Ith, Ian Carroll, Matthew Smuck, Brian Hargreaves(2015). [18F]FDG PET/MRI of patients with chronic pain alters management: early experience . EJNMMI Physics. 2. (S1). Springer Science and Business Media {LLC}

Ka-Wah Tung, Deepak Behera, Sandip Biswal(2015). Neuropathic Pain Mechanisms and Imaging . Seminars in Musculoskeletal Radiology. 19. (02). p. 103--111. Georg Thieme Verlag {KG}

James, Michelle L., Shen, Bin, Nielsen, Carsten H., Behera, Deepak, Buckmaster, Christine L., Mesangeau, Christophe, Zavaleta, Cristina, Vuppala, Pradeep K., Jamalapuram, Seshulatha, Avery, Bonnie A., et al.(2014). Evaluation of sigma-1 Receptor Radioligand F-18-FTC-146 in Rats and Squirrel Monkeys Using PET. Journal of Nuclear Medicine. 55. (1). p. 147-153.

Hoehne, Aileen, Behera, Deepak, Parsons, William H., James, Michelle L., Shen, Bin, Borgohain, Preeti, Bodapati, Deepika, Prabhakar, Archana, Gambhir, Sanjiv S., Yeomans, David C., et al.(2013). A F-18-Labeled Saxitoxin Derivative for in Vivo PET-MR Imaging of Voltage-Gated Sodium Channel Expression Following Nerve Injury . Journal of the American Chemical Society. 135. (48). p. 18012-18015.

Liqin Xiong, Bin Shen, Behera, D., Gambhir, S.S., Chin, F.T., Jianghong Rao(2013). Synthesis of ligand-functionalized water-soluble [ F]YF nanoparticles for PET imaging . Nanoscale. 5. (8). p. 3253-6.

Xiong, L., Shen, B., Behera, D., Gambhir, S. S., Chin, F. T., Rao, J.(2013). Synthesis of ligand-functionalized water-soluble [(18)F]YF3 nanoparticles for PET imaging . Nanoscale.

Xiong, Liqin, Shen, Bin, Behera, Deepak, Gambhir, Sanjiv S., Chin, Frederick T., Rao, Jianghong(2013). Synthesis of ligand-functionalized water-soluble [F-18]YF3 nanoparticles for PET imaging . Nanoscale. 5. (8). p. 3253-3256.

Behera, Deepak, Behera, Subrat, Jacobs, Kathleen E, Biswal, Sandip(2013). Bilateral peripheral neural activity observed in vivo following unilateral nerve injury. American journal of nuclear medicine and molecular imaging. 3. (3). p. 282-90.

Wilmot, Andrew, Gieschler, Simone, Behera, Deepak, Gade, Terence P., Reumann, Marie K., Biswal, Sandip, Mayer-Kuckuk, Philipp(2013). Molecular Imaging: An Innovative Force in Musculoskeletal Radiology . American Journal of Roentgenology. 201. (2). p. 264-277.

Jacobs, Kathleen E., Behera, Deepak, Rosenberg, Jarrett, Gold, Garry, Moseley, Michael, Yeomans, David, Biswal, Sandip(2012). Oral manganese as an MRI contrast agent for the detection of nociceptive activity . Nmr in Biomedicine. 25. (4). p. 563-569.

Ghanouni, Pejman, Behera, Deepak, Xie, Jin, Chen, Xiaoyuan, Moseley, Michael, Biswal, Sandip(2012). In vivo USPIO magnetic resonance imaging shows that minocycline mitigates macrophage recruitment to a peripheral nerve injury . Molecular Pain. 8.

Behera D, Jacobs KE, Behera S, Rosenberg J, Biswal S., 2011, '(18)F-FDG PET/MRI can be used to identify injured peripheral nerves in a model of neuropathic pain.', J Nucl Med, 2011, 52(8):1308-12 .

Behera, D., Jacobs, K. E., Behera, S., Rosenberg, J., Biswal, S.(2011). (18)F-FDG PET/MRI can be used to identify injured peripheral nerves in a model of neuropathic pain . J Nucl Med. 52. (8). p. 1308-12.

Behera, Deepak, Jacobs, Kathleen E., Behera, Subrat, Rosenberg, Jarrett, Biswal, Sandip(2011). F-18-FDG PET/MRI Can Be Used to Identify Injured Peripheral Nerves in a Model of Neuropathic Pain . Journal of Nuclear Medicine. 52. (8). p. 1308-1312.

Mulcahy, J. V., Biswal, S., Yeomans, D., Du Bois, J., Behera, D., Miljanich, G.(2011). Design of sodium channel inhibitors patterned on saxitoxin as therapeutics for the treatment of pain. Society for Neuroscience Abstract Viewer and Itinerary Planner. 41.

Biswal, S., Parsons, W., Hoehne, A., Shen, B., Behera, D., Chin, F., Mulcahy, J., Miljanich, G. P., Yeomans, D., Du Bois, J.(2011). Imaging pain generators in vivo using positron emission tomography (PET)-labeled sodium channel toxin derivatives. Society for Neuroscience Abstract Viewer and Itinerary Planner. 41.

Hoehne, Aileen, Parsons, William H., Behera, Deepak, Shen, Bin, Gambhir, Sanjiv S., Du Bois, Justin, Biswal, Sandip, Chin, Frederick T.(2011). Radiolabeling of a Saxitoxin derivative for PET-MRI imaging of pain. Journal of Labelled Compounds & Radiopharmaceuticals. 54. p. S2.

Anuradha Kolluru, Rakesh Lattupalli, Manreet Kanwar, Deepak Behera, Desikan Kamalakannan, Muhammed K Beeai, 2010, 'Postpartum ovarian vein thrombosis presenting as ureteral obstruction', BMJ Case Reports 2010 .

Mulcahy, J. V., Parsons, W. H., Ondrus, A. E., Andresen, B. M., Behera, D., Hoehne, A., Chin, F. T., Yeomans, D. C., Biswal, S., Miljanich, G. P., et al.(2010). Sodium channel inhibitors patterned on saxitoxin as diagnostics and therapeutics for the treatment of pain. Society for Neuroscience Abstract Viewer and Itinerary Planner. 40.

(2010). Postpartum ovarian vein thrombosis presenting as ureteral obstruction .

Kai Chen, Jin Xie, Hengyi Xu, Behera, D., Michalski, M.H., Biswal, S., Wang, A., Xiaoyuan Chen(2009). Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting . Biomaterials. 30. (36). p. 6912-19.

Chen, K, Xie, J, Xu, H, Behera, D, Michalski, M, Biswal, S, Wang, A & Chen, X, 2009, 'Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting', vol. 30, no. 36, pp. 6912-6919 .

Ghanouni, P, Behera, D, Xie, J, Chen, X, Moseley, M & Biswal, S, 2012, 'In vivo USPIO magnetic resonance imaging shows that minocycline mitigates macrophage recruitment to a peripheral nerve injury', vol. 8, no. 1, p. 49 .

Jacobs, K, Behera, D, Rosenberg, J, Gold, G, Moseley, M, Yeomans, D & Biswal, S, 2012, 'Oral manganese as an MRI contrast agent for the detection of nociceptive activity', vol. 25, no. 4, pp. 563-569 .